Sophie Besse Selected Research

Sophie Besse Research Topics

Disease

15	Melanoma (Melanoma, Malignant) 03/2021 - 09/2012
14	Neoplasms (Cancer) 03/2021 - 04/2013
5	Chondrosarcoma 09/2017 - 01/2011
2	Hypoxia (Hypoxemia) 02/2006 - 02/2002
2	Ischemia 09/2004 - 06/2002
1	Heart Failure 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Lymphatic Metastasis 03/2021
1	Extranodal Extension 03/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Circulating Neoplastic Cells 11/2019
1	Breast Neoplasms (Breast Cancer) 11/2018
1	Colorectal Neoplasms (Colorectal Cancer) 03/2017
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Myocardial Infarction 04/2013
1	Brain Ischemia (Cerebral Ischemia) 04/2013
1	Acidosis 02/2006
1	Sepsis (Septicemia) 01/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2003
1	Contracture 02/2003
1	Cardiotoxicity 02/2003
1	Hypertension (High Blood Pressure) 06/2002

Drug/Important Bio-Agent (IBA)

11	Melanins (Melanin)IBA 10/2020 - 09/2012
9	N- (2- diethylaminoethyl)- 6- iodoquinoxaline- 2- carboxamideIBA 03/2021 - 09/2013
9	Radioisotopes (Radionuclides)IBA 03/2021 - 05/2013
5	LigandsIBA 01/2021 - 05/2014
4	Proteoglycans (Proteoglycan)IBA 09/2017 - 01/2011
3	Ammonium CompoundsIBA 09/2017 - 08/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 04/2013
2	Biological ProductsIBA 11/2018 - 05/2014
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2017 - 11/2014
2	IodineIBA 03/2016 - 11/2013
2	Iodine-125IBA 01/2015 - 05/2013
2	cariporideIBA 02/2006 - 09/2004
2	SodiumIBA 02/2006 - 09/2004
2	Protons (Proton)IBA 02/2006 - 09/2004
2	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2006 - 02/2002
1	CytokinesIBA 01/2022
1	ChemokinesIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2021
1	AntigensIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 10/2020
1	eumelaninIBA 04/2019
1	AnionsIBA 04/2019
1	pheomelaninIBA 04/2019
1	AcetyltransferasesIBA 11/2018
1	ChromatinIBA 11/2018
1	Small Interfering RNA (siRNA)IBA 11/2018
1	Pharmaceutical PreparationsIBA 09/2017
1	Doxycycline (Periostat)FDA LinkGeneric 09/2017
1	Matrix Metalloproteinase InhibitorsIBA 09/2017
1	DNA (Deoxyribonucleic Acid)IBA 03/2017
1	TetraspaninsIBA 03/2017
1	PolymersIBA 01/2017
1	A-Form DNA (A-DNA)IBA 03/2016
1	F 4 (F-4)IBA 03/2015
1	Peptides (Polypeptides)IBA 02/2015
1	N,N-diethylethylenediamineIBA 02/2015
1	4-Nle-7-Phe-alpha- MSHIBA 02/2015
1	IntegrinsIBA 02/2015
1	Idoxuridine (Stoxil)FDA LinkGeneric 01/2015
1	Iodine-123IBA 01/2015
1	IndiumIBA 11/2014
1	GadoliniumIBA 11/2014
1	Siloxanes (Siloxane)IBA 11/2014
1	AmidesIBA 05/2014
1	QuinoxalinesIBA 05/2014
1	Antineoplastic Agents (Antineoplastics)IBA 05/2014
1	FluorineIBA 11/2013
1	Zoledronic Acid (Zometa)FDA Link 05/2013
1	Phosphates (Orthophosphate)IBA 05/2013
1	Iodine-131IBA 05/2013
1	Fluorine-18IBA 05/2013
1	pleiotrophin (HARP)IBA 04/2013
1	Heparin (Liquaemin)FDA LinkGeneric 04/2013
1	pyridineIBA 09/2012
1	Melphalan (Alkeran)FDA LinkGeneric 08/2012
1	CalciumIBA 02/2006
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2006
1	AntioxidantsIBA 01/2006
1	EnzymesIBA 01/2006
1	SeleniumIBA 05/2003
1	Deferoxamine (Desferal)FDA LinkGeneric 02/2003
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2003
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 06/2002
1	ReninIBA 06/2002
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 02/2002
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 02/2002

Therapy/Procedure

15	Therapeutics 01/2022 - 08/2012
2	Immunotherapy 10/2020 - 03/2017
1	Radioimmunotherapy 03/2017
1	Precision Medicine 01/2017
1	Radiotherapy 01/2015
1	Complementary Therapies (Alternative Medicine) 09/2013
1	Drug Therapy (Chemotherapy) 09/2013
1	Intravenous Injections 04/2013